Which probably depends on PFS and then DFS being completed. The road would help to better guarantee it (by locking in some lower costs).
The other alternative is a Stibium fast-track - if it's deemed simple enough to predict and cheap enough to fund, to be able to ignore certain studies.
General Chat, page-7959
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NVA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.025(16.7%) |
Mkt cap ! $42.62M | |||
| Open | High | Low | Value | Volume |
| 16.5¢ | 17.5¢ | 16.5¢ | $14.47K | 85.49K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 25000 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 15528 | 2 |
View Market Depth
| Last trade - 10.39am 17/09/2024 (20 minute delay) ? |
| NVA (ASX) Chart |